你即將離開本站

並前往https://lifesci.nyc/news/rgenix-bags-40m-advance-cancer-drugs-including-gsk-castoff

Rgenix bags $40M to advance cancer drugs, including GSK ...

RGX-104, the immunotherapy and Rgenix's lead asset, is designed to target the LXR/APoE pathway that regulates the innate immune response in cancer.

確定！ 回上一頁

查詢 「GSK 104」的人也找了：

  1. MSD 104
    2.
  2. 諾華104
    3.
  3. gsk台灣裁員
    4.
  4. GSK 104
    5.
  5. gsk薪水ptt
    6.
  6. gsk流感疫苗
    7.
  7. gsk面試
    8.
  8. gsk台灣股票
    9.